The estimation was derived by two methods : correlation of the percent efficacy and the antibody distribution profile in the vaccine group at a given period of observation , and use of the relative ratio of anti-Vi IgG levels between the vaccine and placebo groups greater or equal to the Relative Risk of typhoid fever used in the efficacy determination .